GCTK Projected Dividend Yield

Com Par $0.001/GlucoTrack Inc ( NASDAQ : GCTK )

GlucoTrack is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. Co. has developed a non-invasive glucose monitor, the GlucoTrack® glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings. The GlucoTrack utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements via a sensor that is clipped onto one's earlobe and connected to a handheld control and display unit without drawing blood or interstitial fluid.

20 YEAR PERFORMANCE RESULTS